Télécharger le supplément (250 p.) - KCE

More documents

Recommendations

Info

144 Médecine à l'acte / médecine au forfait - ANNEXES KCE Reports 85 S Source DF Type I SS Mean Square F Value Pr > F age*inv 5 1337040.00 267408.00 9.65
KCE Reports 85 S Médecine à l'acte : médecine au forfait - ANNEXES 145 Parameter Estimate Standard Error t Value Pr > |t| age*inv 1-4 ans 2 0.0000000 B . . . age*inv 25-39 ans 1 221.6499481 B 69.85664873 3.17 0.0015 age*inv 25-39 ans 2 0.0000000 B . . . age*inv 40-64 ans 1 188.6457465 B 68.86719302 2.74 0.0062 age*inv 40-64 ans 2 0.0000000 B . . . age*inv 5-24 ans 1 133.7952986 B 69.25093501 1.93 0.0534 age*inv 5-24 ans 2 0.0000000 B . . . age*inv 65-74 ans 1 301.1731687 B 93.16557270 3.23 0.0012 age*inv 65-74 ans 2 0.0000000 B . . . age*inv 75-84 ans 1 0.0000000 B . . . age*inv 75-84 ans 2 0.0000000 B . . . age*inv 85-+ ans 2 0.0000000 B . . . age*PP0020 1-4 ans 1 -24.2527537 B 42.88620482 -0.57 0.5717 age*PP0020 1-4 ans 2 0.0000000 B . . . age*PP0020 25-39 ans 1 -94.5142708 B 41.16900290 -2.30 0.0217 age*PP0020 25-39 ans 2 0.0000000 B . . . age*PP0020 40-64 ans 1 -93.3673096 B 41.12929867 -2.27 0.0232 age*PP0020 40-64 ans 2 0.0000000 B . . . age*PP0020 5-24 ans 1 -34.0402586 B 41.08811924 -0.83 0.4074 age*PP0020 5-24 ans 2 0.0000000 B . . . age*PP0020 65-74 ans 1 -32.8316298 B 41.91196664 -0.78 0.4334 age*PP0020 65-74 ans 2 0.0000000 B . . . age*PP0020 75-84 ans 1 -22.7402388 B 42.96606614 -0.53 0.5966 age*PP0020 75-84 ans 2 0.0000000 B . . . age*PP0020 85-+ ans 1 0.0000000 B . . . age*PP0020 85-+ ans 2 0.0000000 B . . . age*chom3 1-4 ans 2 0.0000000 B . . . age*chom3 25-39 ans 1 19.9634299 B 44.18796144 0.45 0.6514 age*chom3 25-39 ans 2 0.0000000 B . . . age*chom3 40-64 ans 1 22.7924544 B 44.22112293 0.52 0.6063 age*chom3 40-64 ans 2 0.0000000 B . . . age*chom3 5-24 ans 1 59.2337687 B 44.83392835 1.32 0.1865 age*chom3 5-24 ans 2 0.0000000 B . . . age*chom3 65-74 ans 1 0.0000000 B . . . age*chom3 65-74 ans 2 0.0000000 B . . . age*chom3 75-84 ans 2 0.0000000 B . . . age*chom3 85-+ ans 2 0.0000000 B . . . im*inv 1 1 -50.3442705 B 11.47952634 -4.39
Page 1 and 2:
Comparaison du coût et de la quali
Page 3 and 4:
Comparaison du coût et de la quali
Page 5 and 6:
KCE Reports 85 S Médecine à l’a
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98: KCE Reports 85 S Médecine à l’a
Page 113 and 114: KCE Reports 85 S Médecine à l'act
Page 147: KCE Reports 85 S Médecine à l'act
Page 199 and 200:
KCE Reports 85 S Médecine à l'act
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
This page is left intentionally bla
Page 247 and 248:
KCE reports 1. Efficacité et renta
Page 249:
74. Oxygénothérapie Hyperbare: Ra
show all

Télécharger le supplément (250 p.) - KCE

Create successful ePaper yourself

Delete template?

Save as template?